On January 22, LIVZON PHARMA (01513) spent 117.54 million yuan to repurchase 326,000 A shares.

date
22/01/2025
avatar
GMT Eight
LIVZON PHARMA (01513) announced that it will spend 117.54 million RMB to repurchase 326,000 A shares on January 22, 2025.
pre
HG SEMI(06908): The subscription rate for the rights issue is approximately 74.74%
CHINARES PHARMA(03320): China Resources Boya Bio-pharmaceutical Group(300294.SZ) expects the net profit attributable to the parent company to increase by about 380-480 million yuan in 2024 compared to the previous year.
next

RECOMMEND

recommend

HK Stock Market Move | YUEXIU PROPERTY (00123) fell more than 4% after issuing a profit warning. The company expects its core net profit for the full year to decline by up to 55% year-on-year.

date
6 min ago
recommend

HK Stock Market Move | MEDBOT-B(02252) rose more than 3% against the market trend, with strong company order trends and potential benefits from the rapid expansion of Siasun Robot & Automation at home and abroad.

date
6 min ago
recommend

HK Stock Market Move | Xiabuxiabu (00520) fell by more than 3% after issuing a profit warning, with an expected increase in losses compared to last year to around 390 million to 410 million yuan.

date
9 min ago

©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.

Contact: contact@gmteight.com